Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Michael D. Prados, Daphne A. Haas‐Kogan, Nicholas Butowski et al.|Journal of Clinical Oncology|2008

Cited by 377